CyDex Pharmaceuticals, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 108
Rang # Quantité totale PI 12 067
Note d'activité PI 2,4/5.0    30
Rang # Activité PI 25 835
Parent Ligand Pharmaceuticals Incorporated
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

52 10
15 2
23 4
2
 
Dernier brevet 2024 - Injectable melphalan composition...
Premier brevet 1997 - Sulfoalkyl ether cyclodextrin ba...
Dernière marque 2024 - O
Première marque 1994 - CAPTISOL

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Scientific laboratory services Solubilizing chemical agents for use in the manufacture of a wide ...
P/S Solubilizing chemical agents for use in the manufacture of a wide variety of goods Scientific lab...
2023 Invention Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and ...
Invention Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of maki...
2022 Invention Composition containing cyclodextrin and busulfan. Pharmaceutical formulations containing busulfa...
Invention Composition containing sulfoalkyl ether cyclodextrin and latanoprost. An aqueous composition of ...
Invention Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same...
2021 Invention Manufacturing process for cyclodextrin derivatives. A process and equipment assembly for reactin...
Invention Alkylated cyclodextrin compositions and processes for preparing and using the same. The present ...
Invention Alkylated cyclodextrin compositions and processes for preparing and using the same. The present d...
Invention Nasal and ophthalmic delivery of aqueous corticosteroid solutions. The present invention is dire...
2020 Invention Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same. ...
Invention Sulfoalkyl ether cyclodextrin compositions. SAE-CD compositions are provided, along with methods ...
Invention Dpi formulation containing sulfoalkyl ether cyclodextrin. An inhalable dry powder formulation con...
Invention Manufacturing process for cyclodextrin derivatives. A process and equipment assembly for reacting...
2019 Invention Composition containing sulfoalkyl ether cyclodextrin and latanoprost. An aqueous composition of l...
Invention Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof. A particulate SAE-...
2018 Invention Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid. An inhalable f...
Invention Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid. An inhalable fo...
Invention Alkylated cyclodextrin compositions and processes for preparing and using the same. The present i...
Invention Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use. The pre...
Invention Composition containing cyclodextrin and busulfan. Pharmaceutical formulations containing busulfan...
2017 Invention Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin. Pharmaceutical formulat...
Invention Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin. Pharmaceutical formulati...
2016 Invention Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of maki...
P/S Solubilizing agents; Solubilizing chemical agents for use in the manufacture of pharmaceutical pr...
P/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations Licensing ...
P/S Licensing of excipient pharmaceutical products.
P/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations.
2015 P/S Chemical agents for use in pharmaceutical products, namely, solubilizing agents; solubilizing che...
2014 P/S Solubilization chemicals for medical diagnostic research.
P/S Solubilization chemicals for diagnostic research.
2009 P/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations
2008 P/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations. Pharmace...
2007 P/S [ pharmaceuticals for the treatment of CNS diseases and/or disorders, oncology, and pain indicati...
1997 P/S Sulfobutylether substituted cyclodextrins for use in chemical analysis, primarily via capillary e...
1994 P/S solubilization chemicals for diagnostic research